If you think that 2019 has been a year full of twists and turns for marijuana stocks, just wait. There's plenty of action remaining to be seen in the last two months of the year. And there are several big events happening this month.
The U.S. Senate on Thursday approved a spending bill that includes a provision that would continue to protect state-legal medical marijuana programs from U.S. Department of Justice interference.
The provision, which would be good for a year, was included for the first time in the House fiscal year 2020 Commerce-Justice-Science bill.In the past, the provision has been tacked on as an amendment either on the House floor or in committee.
The Senate passed the spending bill with the medical marijuana protections by an 84-9 vote.
We’re hardly California or Colorado, but Florida is emerging as one of the nation’s top pot states.
The latest evidence comes in a new study that forecasts legal marijuana sales in Florida will grow by 6 percent over the next five years — by $1.3 billion.
Florida’s high population could make it one of the top three states for the sale of cannabis products, according to a new report by Arcview Market Research and BDS Analytics, which track the industry.
It's been a little over a year since Canada legalized marijuana for recreational use. Oct. 17 also marked the opening of the new cannabis market in Canada that will include beverages and other derivatives, although products won't be available to purchase until at least December. While there will be some challenges ahead for the new segment of the cannabis market, it's hard to imagine the next 12 months will be as hectic as the past year has been.
Cannabis stocks were mostly lower Thursday, led by Curaleaf Holdings, after the company became the latest to scale back a previously announced acquisition following a massive re-rating of risk in the sector in the past few months.
While seniors are less likely to use cannabis than other age groups, consumption in that particular demographic is growing at a faster rate compared to others, a new Statistics Canada survey said Wednesday.
“Cannabis use is less common among seniors than it is in other age groups (7 per cent, compared with 10 per cent at ages 45 to 64, 25 per cent at ages 25 to 44, and 26 per cent at ages 15 to 24),” a Statistics Canada release said. “However, cannabis consumption among seniors has been accelerating at a much faster pace than it has among other age groups.”
Most hemp farmers across the country got a big boost when the United States Department of Agriculture released its first round of industrial hemp regulations earlier this week; the new rules took effect today, October 31.
On 1 November 2018, the law was changed in Britain to allow clinicians on the General Medical Council’s (GMC) Specialist Register to be prescribed unlicensed cannabis products. The change in law was driven by the efforts of the families of Alfie Dingley and Billy Caldwell, two children who suffer from serious epilepsy.
UNITED STATES - SEPTEMBER 7: U.S Secretary of Agriculture Sonny Perdue announced the establishment of the U.S. Domestic Hemp Production Program this week, a program that creates a regulatory framework around the production of hemp in the United States. The program was required by the 2018 Farm Bill.
Despite a series of obstacles and setbacks, California’s legal marijuana market is on track to continue growing in the coming years, according to a new report.
By 2024, cannabis sales growth in the Golden State will account for nearly a quarter of all sales growth in the United States, according to a report, “From Dispensaries to Superstores: Opportunities in U.S. Cannabis Retail,” issued by BDS Analytics and ArcView Market Research.
California voters legalized recreational use of marijuana in 2016, with sales becoming legal on Jan. 1, 2018.
